ADVANCED PROTEOME THERAPEUTICS CORPORATION Advanced Proteome Therapeutics Corporation Share Price
Equities
APC.H
CA0076282098
Investment Holding Companies
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -.--% |
|
-.--% | -.--% |
| Sales 2021 | - | Sales 2022 | - | Capitalization | 4.65M 6.35M 388M |
|---|---|---|---|---|---|
| Net income 2021 | -1M -1.37M -83.43M | Net income 2022 | - 0 0 | EV / Sales 2021 | - |
| Net cash position 2021 | 324K 442K 26.99M | Net cash position 2022 | 31.61K 43.2K 2.64M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-4.85
x | P/E ratio 2022 |
6.03
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 89.84% |
More Fundamentals
* Assessed data
More news
1 year
0.01
0.03
3 years
0.010.46
5 years
0.010.51
10 years
0.013.20
| Managers | Title | Age | Since |
|---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/18/16 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10/09/10 |
Martin Woodward
BRD | Director/Board Member | 56 | 20/18/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20/18/20 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21/22/21 |
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.
Sector
Investment Holding Companies
Calendar
25/06/2024
- Q3 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 150K | |
| +166.80% | 5.68B | |
| +1.65% | 1.01B | |
| +2.05% | 982M | |
| +41.91% | 872M | |
| +24.28% | 819M | |
| +1.72% | 663M | |
| +1.80% | 610M | |
| -.--% | 600M | |
| +36.55% | 552M |
- Stock Market
- Equities
- APC.H Stock
